Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance

Endocrine Reviews · Published 2025-02-25 · DOI 10.1210/endrev/bnae032

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1210/endrev/bnae032

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• GLP-1 receptor agonists in type 1 diabetes: expanding the therapeutic landscape beyond insulin · The Lancet Regional Health. Europe · 2026 · Cites or is cited by this article
• Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion · Endocrine Reviews · 2025 · Same journal
• The metabolic roles of immune checkpoint molecules · Endocrine Reviews · 2026 · Same journal
• Glycated CD59: a novel biomarker for gestational diabetes · Endocrine Reviews · 2026 · Same journal
• Regulatory cycles of orexin and glucagon-Like peptide-1 in postviral syndromes · Endocrine Reviews · 2026 · Same journal
• Novel GLP-1-based Medications for Type 2 Diabetes and Obesity · Endocrine Reviews · 2025 · Same journal
• The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens · Endocrine Reviews · 2025 · Same journal
• Diverse SOX3 genetic variants and their associated phenotypic spectrum in human disease · Endocrine Reviews · 2026 · Same journal
• Epigenetics and disease progression in neuroendocrine neoplasms · Endocrine Reviews · 2026 · Same journal
• Historical Aspects of Testicular Function: Virility, Androgen Production, and Spermatogenesis · Endocrine Reviews · 2025 · Same journal